EFFICACY AND SAFETY OF CHEMOTHERAPIES FOR ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS WITH INTERSTITIAL PNEUMONIA

被引：0
|
作者：
Sakai, M. [1 ]
Kubota, T. [1 ]
Kawase, S. [1 ]
Miyamoto, S. [1 ]
Yokoyama, A. [1 ]
机构：
[1] Kochi Univ, Dept Hematol & Resp Med, Kochi, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt460.17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF PEMETREXED FOR NON-SMALL CELL LUNG CANCER PATIENTS WITH IDIOPATHIC INTERSTITIAL PNEUMONIA
    Kato, M.
    Takahashi, F.
    Koyama, R.
    Muraki, K.
    Ko, R.
    Kobayashi, I.
    Murakami, A.
    Hoshika, Y.
    Shyukuya, T.
    Ohashi, R.
    Shimada, N.
    Sakuraba, A.
    Takahashi, K.
    [J]. RESPIROLOGY, 2012, 17 : 89 - 89
  • [2] Vinorelbine and Cisplatin in Patients with Advanced Non-small Cell Lung Cancer with Interstitial Pneumonia
    Watanabe, Naohiro
    Niho, Seiji
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Ohmatsu, Hironobu
    Goto, Koichi
    [J]. ANTICANCER RESEARCH, 2015, 35 (03) : 1697 - 1701
  • [3] Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer
    Zhong, Yuejiao
    Wei, Qiang
    Lu, You
    Tang, Xiuliang
    Wang, Zhongqiu
    Chen, Lingxiang
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 6016 - 6022
  • [4] Safety and efficacy of bevacizumab in "fragile" patients with advanced non-small cell lung cancer
    Maragkos, C.
    Grapsa, D.
    Koumakis, G.
    Polyzos, A.
    Syrigos, K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [5] Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer
    Aiqin Gu
    Chunlei Shi
    Liwen Xiong
    Tianqing Chu
    Jun Pei
    Baohui Han
    [J]. Chinese Journal of Cancer Research, 2013, 25 (01) : 90 - 94
  • [6] Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer
    Gu, Aiqin
    Shi, Chunlei
    Xiong, Liwen
    Chu, Tianqing
    Pei, Jun
    Han, Baohui
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (01) : 90 - 94
  • [7] Efficacy and safety of second-line chemotherapy for patients with advanced non-small cell lung cancer complicated by interstitial lung disease
    Otsuka, Kenji
    Nokihara, Hiroshi
    Mitsuhashi, Atsushi
    Ozaki, Ryohiko
    Yabuki, Yohei
    Yoneda, Hiroto
    Ogino, Hirokazu
    Nishioka, Yasuhiko
    [J]. THORACIC CANCER, 2022, 13 (21) : 2978 - 2984
  • [8] Efficacy and safety of nivolumab in non-small cell lung cancer with preexisting interstitial lung disease
    Kanai, Osamu
    Kim, Young Hak
    Demura, Yoshiki
    Kanai, Makiko
    Ito, Tsuyoshi
    Fujita, Kohei
    Yoshida, Hironori
    Akai, Masaya
    Mio, Tadashi
    Hirai, Toyohiro
    [J]. THORACIC CANCER, 2018, 9 (07) : 847 - 855
  • [9] Efficacy and safety of domestic and imported gefitinib in patients with advanced non-small cell lung cancer
    Cheng, Huawei
    Liu, Hongyue
    Du, Qiong
    Zhang, Hui
    Zhang, Xiaodan
    Wang, Yangkui
    Shao, Jingjing
    Yang, Feng
    Zhang, Bo
    Shi, Jing
    Liu, Yuguo
    Wu, Nan
    Xu, Silu
    Wei, Qing
    Sun, Yancai
    Zhai, Qing
    Yu, Bo
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (01) : 10 - 15
  • [10] Efficacy and Safety of Nivolumab in Non-Small Cell Lung Cancer with Preexisting Interstitial Lung Disease
    Kanai, O.
    Kim, Y.
    Demura, Y.
    Kanai, M.
    Fujita, K.
    Yoshida, H.
    Akai, M.
    Mio, T.
    Hirai, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2420 - S2420
12345